Aytu Biopharma (AYTU) Goodwill & Intangibles (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Goodwill & Intangibles of $42.5 million for Q1 2026, down 40.55% year-over-year from $71.5 million in Q1 2025, and down 27.24% quarter-over-quarter from $58.4 million in Q4 2025.
Aytu Biopharma (AYTU) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Goodwill & Intangibles for 12 consecutive years, with $42.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 40.55% year-over-year to $42.5 million; the TTM figure through Mar 2026 stood at $42.5 million (down 40.55% YoY), while the FY2025 annual figure was $42.2 million, down 19.55% from the prior year.
- Goodwill & Intangibles slipped to $42.5 million in Q1 2026 per AYTU's latest filing, from $58.4 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $94.2 million in Q2 2022 and bottomed at $41.4 million in Q3 2025.
- Historically, Goodwill & Intangibles has averaged $66.3 million across 5 years, with a median of $59.0 million in 2023.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles increased 22.31% — and 2026, when it tumbled 40.55%.
- Aytu Biopharma's Goodwill & Intangibles stood at $89.6 million in 2022, then sank by 37.79% to $55.7 million in 2023, then retreated by 10.33% to $50.0 million in 2024, then grew by 16.9% to $58.4 million in 2025, then slipped by 27.24% to $42.5 million in 2026.
- Business Quant data shows AYTU's Goodwill & Intangibles at $42.5 million in Q1 2026, $58.4 million in Q4 2025, and $41.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.49 Mn |
| Dec 31, 2025 | 58.40 Mn |
| Sep 30, 2025 | 41.43 Mn |
| Jun 30, 2025 | 42.20 Mn |
| Mar 31, 2025 | 71.47 Mn |
| Dec 31, 2024 | 49.96 Mn |
| Sep 30, 2024 | 51.21 Mn |
| Jun 30, 2024 | 52.45 Mn |
| Mar 31, 2024 | 77.87 Mn |
| Dec 31, 2023 | 55.71 Mn |
| Sep 30, 2023 | 78.58 Mn |
| Jun 30, 2023 | 58.97 Mn |
| Mar 31, 2023 | 89.55 Mn |
| Dec 31, 2022 | 89.55 Mn |
| Sep 30, 2022 | 89.55 Mn |
| Jun 30, 2022 | 94.22 Mn |
| Mar 31, 2022 | 83.07 Mn |
| Dec 31, 2021 | 127.69 Mn |
| Sep 30, 2021 | 140.57 Mn |
| Jun 30, 2021 | 151.27 Mn |